Weight loss with Acomplia has worked out for many over weight people and can work for you too. Acomplia diet pills can be used by virtually any age group and by individuals of any activity level.

Popularly known as Rimonabant, Acomplia is becoming a wonder drug for treating overweight significantly. Developed by French pharmaceutical company Sanofi- Aventis is successful in showing immense promise to majority of people suffering from obesity or overweight.

So far the simple perspective of weight loss was through dieting and exercising vigorously. But in most cases the results proved to be mere temporary. But medically it has been proved successfully that if Acomplia goes along with your diet and exercise, the results can be magical.

Clinical trials proved that 35% of patients on Acomplia (Rimonabant) lost 10%-12% of their body weight and kept their weight down for more than 2 years which is a record as no other diet pill has managed to keep a person’s weight for so long. Most interestingly, according to studies, apart from lowering body mass, it is believed to help a person by stopping his or her’s urges for nicotine. So it is believed to provide dual benefit to its users.

Now let us see how it’s happen. There are various nerve receptors called CB1 receptors in our brain as well as our fat cells. The signals from these receptors are responsible to make a body hungry and often increase the urge for smoking. Acomplia blocks the signals of these receptors and stops our urges to over eat.

Acomplia have consistently provided quality results and lasting benefits. It allows us to live at our own pace and doesn’t allow us to slack off.

FDA is continuously studying and observing its affects especially on its smoking cessation quality. And once approved it is sure to rule the overweight market for the dual benefits associated with it.

If you really want to lose weight, you can do that. It is very important to have a great help too. All we want to do is to offer you the possibility to have all the help you need. All we want to do is to offer you Acomplia at a very good price so you can afford it. Now you do not have to worry because the pills are too expensive because if you buy Acomplia online now from our website you will see and feel the difference. Buy Acomplia online make your life better and more pleasant!

Buy Acomplia online and you will see the difference. This means that you can take advantage by acomplia. This is a medicine that will act on your CB1 receptors. Actually it will block these receptors and this is a good sign. I said that because these receptors are responsible for the need to eat more and more and for the urge to smoke. By blocking these CB1 receptors acomplia will help you not to eat more than you need and you will also be able to quit smoking. And this is great because is you are a smoker and you are afraid to quit because you can get fat, now is the time to do that. You can lose weight and quit smoking in the same time and with the same pill. Nothing easier: buy acomplia online and solve your problems.

With Acomplia it will be easy for you to lose weight and to achieve the body shape you ever wanted. But you must know that it would be better for you if you choose to help this medicine too. Helping this medicine means to follow a good diet and make some controlled exercises. It would be for your best if you choose to go to a doctor before taking Acomplia. In this way you will avoid unpleasant situations. Also if you see a doctor it will help you by recommending you a diet or some exercises.

It is very important to lose weight because over weight and obese people are more likely to suffer from other diseases and medical condition too. Some of the most common diseases that can affect over weight and obese people are heart disease, high blood pressure, cholesterol, diabetes and the list may continue. Therefore it is very important to lose weight. Also therefore it is important to use Acomplia to lose weight.

Buy Acomplia Online now and you can get rid of extra kilograms. The part in your life when you were obese or over weight will be part of your past. After using Acomplia you will be able to obtain the body shape you ever wanted and to be a healthy person. Being healthy and not being obese will make you a happy person. After that all your life will be better and you will be another person. Your life will be different and you will the world with other eyes.
Buy Acomplia Online now and enjoy your new healthy and happy life.

In order to successfully stick with a diet, you need the help of Acomplia. Specifically designed for obese individuals, Acomplia is a diet pill that helps to suppress your urges to eat. Because you aren’t constantly craving food, it is actually possible to maintain a reduced calorie diet and lose weight once and for all.

If you don’t know where to buy Acomplia, the best place is the Internet. The reason that the Internet is the best answer to the question of where to buy Acomplia is because it makes the process quick and simple. So, now that you know where to buy Acomplia, there is no excuse for you not to place your order and take the first step towards making a permanent, healthy change in your life.

Rimonabant (also known as SR141716, Acomplia, Riobant, Slimona, Rimoslim, and Zimulti)[1] is an anorectic anti-obesity drug. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite.

Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m², or patients wih a BMI greater than 27 kg/m² with associated risk factors, such as type 2 diabetes or dyslipidaemia. In the UK, it has been available since the end of July 2006. As of 2007, the drug was available in 38 countries.

Buy Acomplia

NEWS:

Zimulti Acomplia News — Jan. 2008 — News About Rimonabant

Will Diet Drug Taranabant Be This Year’s Rimonabant (Acomplia / Zimulti)?

A year ago at this time, millions of obese Americans were looking forward to FDA approval of diet drug rimonabant (Acomplia / Zimulti). That did not happen — in fact, rimonabant may never make it to market in the U.S. — and the great diet hope for 2008 is Merck’s diet drug taranabant.

Obese Americans eager to hear more about taranabant got a teaser Jan. 10th, but the generally encouraging report in the January issue of the journal Cell Metabolism was again based on results from a phase II trial and not the big phase III trial underway these past two years.

The news, in fact, was very similar to the report on phase II results that Merck presented at the annual scientific meeting of the Obesity Society back on Oct. 24th. In the journal article, researchers said study participants taking varying doses of taranabant lost 8 to 14 pounds over a 12-week period.

But the report did not provide any new insights on the huge outstanding question: Does taranabant have a better side-effect profile than rimonabant?

Both drugs target CB-1 receptors, but Acomplia — which also produced impressive weight loss in trials — failed to make it to the U.S. market last summer after FDA experts voiced concern over rimonabant’s psychiatric side-effects including depression and suicidality?

Merck researchers said between one-fifth and one-third of patients in the phase II trial of taranabant experienced psychiatric adverse effects, including depressed mood, irritability, anger, mood swings, tearfulness, anxiety, insomnia, and nervousness.

But Dr. Steven Heymsfield, global director of scientific affairs, obesity, for Merck Research, said “no suicidal thoughts were reported” in the phase II taranabant study, though he conceded that the question had not been asked in a systemic way.

Presumably, there will be more and better information on side-effect issues when Merck reports on results of its phase III taranabant trial later this year. No date has yet been set for the first reports from this trial.

But clearly, Merck will have to provide information that better addresses the issue of depressive side-effects than was offered by Acomplia developer Sanofi-Aventis if it is to have any hope of obtaining approval of taranabant by the FDA.

The company still expects to submit taranabant for U.S. regulatory approval sometime in 2008.Tags:Buy Acomplia